60 research outputs found

    Philanthropy and Voluntarism Among the Jews

    Get PDF
    This document was part of the Multicultural Philanthropy Project, funded by the W.K. Kellogg Foundation. A series of fourteen guides examine the ways in which various gender, ethnic, cultural, religious and racial groups use their gifts of time, money, and talent. They reflect the ways giving and voluntarism are embedded in American life and challenge the notion that philanthropy is the exclusive province of elites. The guides include discussion topics, research questions, and literature overviews with annotated bibliographies. They were developed both to integrate the study of philanthropy into the curricula at colleges and universities, and to provide a tool to nonprofit professionals in the area of development and fundraising. Each volume provides background information on a selected community that will help practitioners work effectively with these groups. This guide introduces the reader to the religious?cultural and historical origins of modern American Jewish philanthropy and voluntarism, and includes excerpts from traditional religious texts that provide the foundation of the Jewish philanthropic tradition. It considers the centrality of philanthropy and voluntarism to the history of Jewish institutions and cultural movements in American society. It will be of particular use to those seeking to understand Jewish philanthropy and the communal institutions that depend on it. In doing so, the author offers insight into the ties between generosity, theology, and religious structures

    American Religious Identification Survey 2001

    Get PDF

    Identifying the need for good practices in Health Technology Assessment : summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

    Get PDF
    The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support populationbased decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

    Get PDF
    Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≄ II, EF ≀35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

    The Production of Philanthropy: A Case Study of the Imagery & Methodology of Jewish Fundraising

    No full text
    This document was part of the Multicultural Philanthropy Project, funded by the W.K. Kellogg Foundation. A series of fourteen guides examine the ways in which various gender, ethnic, cultural, religious and racial groups use their gifts of time, money, and talent. They reflect the ways giving and voluntarism are embedded in American life and challenge the notion that philanthropy is the exclusive province of elites. The guides include discussion topics, research questions, and literature overviews with annotated bibliographies. They were developed both to integrate the study of philanthropy into the curricula at colleges and universities, and to provide a tool to nonprofit professionals in the area of development and fundraising. Each volume provides background information on a selected community that will help practitioners work effectively with these groups. This guide explores the role of emotions in philanthropic behavior and considers the conscious use of auditory and visual tools as emotional triggers in soliciting donations. Drawing on examples employed by American Jewish organizations, the guide analyzes the emotional structure of fundraising appeals. It will be of particular use to fundraisers, special events coordinators, and creative staff in thinking about ways to craft an effective appeal, and will serve to bring into the open the discussion of the role of emotions in moving the target audience. It is recommended that nonprofit professionals consider the salient issues relevant to their own communities or organizations, using the cases described in this volume as models for comparison, and as spring boards for developing appeals

    Zur anomalen, nicht-linearen Schalldispersion in den Fettsïżœuren

    No full text

    Preface

    No full text

    Preface

    No full text
    • 

    corecore